CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,824 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05764083
NCT05764083N/ACompleted

CSP #2028 - Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3) Within the Veterans Health Administration

VA Office of Research and Development·observational·Posted Mar 10, 2023·Updated Jul 9, 2025

In Brief

An observational study for SARS-CoV-2 and COVID-19. Completed, enrolled 2,824 participants across 1 site.

Detailed Summary

The purpose of this research is to gather information to answer questions about the Coronavirus Disease 2019 (COVID-19) which is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. This study will collect information and biological specimens from participants who have been tested for the SARS-CoV-2 infection. By doing this study, the investigators hope to learn important new information about SARS-CoV-2 infections and the potentially severe outcomes of COVID-19 to find better ways to manage and treat it in the future. The investigators also hope to learn what makes some people more susceptible to infection to help better inform Veterans on how to reduce their risk of infection. This study also involves the development and maintenance of a participant registry, a data repository, and a biorepository for future research.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV-2, COVID-19
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 10, 2023
Enrollment StartJul 22, 2020
Primary CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 3.3 years ago